Avadel Pharmaceuticals PLC (NAS:AVDL)
$ 12.44 -0.23 (-1.82%) Market Cap: 1.20 Bil Enterprise Value: 1.15 Bil PE Ratio: 0 PB Ratio: 17.04 GF Score: 42/100

Avadel Pharmaceuticals PLC at Needham Healthcare Conference Transcript

Apr 11, 2022 / 06:15PM GMT
Release Date Price: $6.72 (-0.59%)
Ami Fadia
Needham & Company, LLC - Analyst

Good afternoon, everyone. Welcome to the session on Avadel. I'm Ami Fadia; I cover neuroscience and targeted oncology here at Needham. And it's my pleasure to be hosting Greg Divis, who is the CEO of the company. Greg, thank you for joining us today and taking the time.

Greg Divis
Avadel Pharmaceuticals plc - CEO

Thanks, Ami. Appreciate the opportunity as always to spend some time with you. Thank you.

Questions & Answers

Ami Fadia
Needham & Company, LLC - Analyst

Perfect. So let's dive straight into the topic that's top of mind for everybody, which is what's going on with FT218 and when might we hear of an update. So in your last conference call and also some other conferences that you've been at in March, you talked about some interactions with the FDA that you've been having. Can you provide us with an update on where those interactions have -- what direction they've taken? Sounds like last time, you were waiting to hear back some feedback from the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot